Sort by
Refine Your Search
-
the synergistic effects of monoclonal antibodies and colistin. Building on extensive preliminary data, the project aims to uncover the mechanisms behind this synergy using advanced biophysical and molecular
-
and AMR markers. By integrating plasmonic signal amplification using gold nanostars with a power-free electrokinetic focusing mechanism, the device will enable early-stage detection without the need
-
such as, but not limited to, chemical, pharmaceutical, biochemical, or mechanical engineering; pharmaceutical sciences; materials science; or related areas. Applicants from computer science with relevant
-
language model (LLM)-based genome design tools with bioprocess engineering to create next-generation therapeutic conjugative plasmids. These engineered plasmids will be optimised for industrial-scale
-
, and biotechnology. Research Environment: The project is a collaboration between UCL Chemistry, Pharmacy, and Chemical Engineering departments. Students will work across multiple labs, benefiting from a
-
for engineering novel antimicrobial peptides. The findings could lead to the development of new therapeutic scaffolds with applications in infectious disease, biotechnology, and immunotherapy. The project also
-
for Doctoral Training in Engineering Solutions for Antimicrobial Resistance. Further details about the CDT and programme can be found at AMR CDT webiste . Applications should be submitted by 12th January 2026.
-
for Doctoral Training in Engineering Solutions for Antimicrobial Resistance. Further details about the CDT and programme can be found at AMR CDT webiste Applications should be submitted by 12th January 2026.